FDX vs KTTAW
FedEx Corporation (FDX) versus Pasithea Therapeutics Corp. Warrant (KTTAW) — a side-by-side from cached financials, not a winner call.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
Pasithea Therapeutics Corp. Warrant (KTTAW) is a biotechnology company listed on US.
Latest reported FDX revenue for 2026-05-31 was $94.72B. Net income was $4.43B. Revenue was up 7.7% from 2025-05-31 to 2026-05-31. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
KTTAW does not have a complete income-statement cache yet.
FDX currently screens at market cap $78.98B and trailing P/E 17.7. KTTAW currently screens at market cap $0.
Not investment advice. Open the FDX and KTTAW stock pages for the full models.
Not investment advice.